<SEC-DOCUMENT>0001178913-25-003921.txt : 20251120
<SEC-HEADER>0001178913-25-003921.hdr.sgml : 20251120
<ACCEPTANCE-DATETIME>20251120084410
ACCESSION NUMBER:		0001178913-25-003921
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20251120
FILED AS OF DATE:		20251120
DATE AS OF CHANGE:		20251120

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sol-Gel Technologies Ltd.
		CENTRAL INDEX KEY:			0001684693
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38367
		FILM NUMBER:		251501187

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		7 GOLDA MEIR ST.
		STREET 2:		WEIZMANN SCIENCE PARK
		CITY:			NESS ZIONA
		NON US STATE TERRITORY:  	L3
		PROVINCE COUNTRY:   	L3
		ZIP:			7403648
		BUSINESS PHONE:		97289313433

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		7 GOLDA MEIR ST.
		STREET 2:		WEIZMANN SCIENCE PARK
		CITY:			NESS ZIONA
		NON US STATE TERRITORY:  	L3
		PROVINCE COUNTRY:   	L3
		ZIP:			7403648
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk2534051.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: zk-global
         Document created using Broadridge PROfile 25.10.1.5333
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div class="BRPFPageHeader">
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"><br>
        <font style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;">UNITED STATES</font></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Washington, D.C. 20549</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">FORM&#160;6-K</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Report of Foreign Private Issuer</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Pursuant to Rule&#160;13a-16&#160;or&#160;15d-16</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Under the Securities Exchange Act of 1934</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">For the month of November 2025</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Commission File Number 001-38367</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">SOL-GEL TECHNOLOGIES LTD.</div>
    <div style="text-align: center; line-height: 1.25;">(Translation of registrant&#8217;s name into English)</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">7 Golda Meir Street</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Ness Ziona 7403650, Israel</div>
    <div style="text-align: center; line-height: 1.25;">(Address of principal executive offices)</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">Indicate by check mark whether the registrant files or will file annual reports under cover Form&#160;20-F&#160;or Form&#160;40-F.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">Form&#160;20-F <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Form&#160;40-F <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">Indicate by check mark if the registrant is submitting the Form&#160;6-K&#160;in paper as permitted by Regulation&#160;S-T&#160;Rule
      101(b)(1):&#160; <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">Indicate by check mark if the registrant is submitting the Form&#160;6-K&#160;in paper as permitted by Regulation&#160;S-T&#160;Rule
      101(b)(7):&#160; <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Explanatory Note</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">On November 20, 2025, Sol-Gel Technologies Ltd. (the &#8220;Company&#8221;) issued a press release announcing
      the Company's financial results for the quarter ended September 30, 2025.</div>
    <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">Attached hereto are the following exhibit:</div>
    <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;"><a href="exhibit_99-1.htm">Exhibit 99.1</a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a href="exhibit_99-1.htm">Press
          release dated November 20, 2025</a></div>
    <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">Exhibit 99.1 (other than the two paragraphs immediately preceding the heading &#8220;Financial Results
      for the Third&#160; Quarter 2025&#8221;) is hereby incorporated by reference into the Company's Registration Statements on Form S-8 (Registration Nos. 333-223915, 333-270477 and 333-286820) and its Registration Statement on Form F-3 (Registration No
      333-286822).</div>
    <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">2<br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">SIGNATURES</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be
      signed on its behalf by the undersigned, thereunto duly authorized.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zc720bbf9bbb74f2aaf7b9e5148499603" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 50%; vertical-align: top;" colspan="2">
            <div style="line-height: 1.25; font-weight: bold;">SOL-GEL TECHNOLOGIES LTD.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: middle;">&#160;</td>
          <td style="width: 4%; vertical-align: middle;">&#160;</td>
          <td style="width: 46%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">Date:&#160; November 20, 2025</div>
          </td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">By:</div>
          </td>
          <td style="width: 46%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="line-height: 1.25;">/s/ Eyal Ben-Or</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 46%; vertical-align: top;">
            <div style="line-height: 1.25;">Eyal Ben-Or</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 46%; vertical-align: top;">
            <div style="line-height: 1.25;">Chief Financial Officer</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; line-height: 1.25;"><br style="line-height: 1.25;">
      <br>
      3</div>
    <div style="text-align: center; line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"> </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div class="BRPFPageFooter">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: zk-global
         Document created using Broadridge PROfile 25.10.1.5333
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
      <div style="text-align: right; line-height: 1.25;"><u><font style="font-weight: bold;"> Exhibit 99.1</font></u><br>
      </div>
      <div style="text-align: center; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: center; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<img height="67" width="329" src="image0.jpg"></div>
      <div style="text-align: center; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Sol-Gel Reports Third Quarter 2025 Financial Results</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> and Provides Corporate Updates</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zddabd70399ff47fc96e537a45e145986">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>Sol-Gel intends to pursue high-frequency BCC as an additional indication for its lead drug candidate SGT-610, which, if approved, could at least double the drug&#8217;s commercial potential<br>
                </div>
              </td>
            </tr>

        </table>
        <br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5d3b3a22ef9a465a8be4f5c5341b7f5e">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div> In September 2025, Sol-Gel announced Health Canada approval of EPSOLAY<br>
                </div>
              </td>
            </tr>

        </table>
        <br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za8bc8c9f8e534d248b136d05a8b7685a">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>Sol-Gel signed an additional agreement with Viatris covering Australia and New Zealand for both EPSOLAY and TWYNEO<br>
                </div>
              </td>
            </tr>

        </table>
        <br style="line-height: 1.25;">
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">NESS ZIONA, Israel, November 20, 2025 (GLOBE NEWSWIRE) - <font style="font-weight: bold;">Sol-Gel Technologies, Ltd.</font>&#160;(NASDAQ: SLGL), a dermatology company, pioneering treatments for patients
      with rare and severe skin conditions, today announced financial results for the third quarter ending September 30, 2025, and provided a corporate update.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Q3 2025 and Recent Corporate Developments</u></div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3622282a010e4311acb52694df8bd887">

          <tr>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Sol-Gel&#8217;s ongoing Phase 3 clinical trial of SGT-610 (patidegib gel, 2%) for Gorlin syndrome, for which top-line results are expected in the fourth quarter of 2026, has led to growing physician interest in its potential use in patients
                with severe, high-frequency basal cell carcinoma (BCC). One such case, a non-Gorlin patient in France with a devastating form of high-frequency BCC, was found to have a lesion harboring a PTCH-1 mutation, and Sol-Gel agreed to provide
                SGT-610 for compassionate use. Sol-Gel plans to supply the drug to additional high-frequency BCC patients with at least one PTCH-1 mutated lesion and is evaluating the initiation of a feasibility study in this new indication to further
                substantiate the rationale for a Phase 3 trial in 2027, subject to the successful completion of the Phase 3 Gorlin syndrome trial. High-frequency BCC is also a rare disease; however, its prevalence is estimated to be at least ten times
                higher than that of Gorlin syndrome. Even if clinical development focuses only on patients with the most severe forms of high-frequency BCC, a successful outcome is expected to at least double the commercial potential of SGT-610. For many
                of these patients, there is a significant unmet need for an effective and well-tolerated treatment, as frequent and potentially disfiguring Mohs surgeries are often no longer sustainable.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="line-height: 1.25"> <br>
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8c53cfcbec074cf981881eb6ce709199">

            <tr>
              <td style="width: 17.85pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>Sol-Gel&#8217;s vehicle-controlled Phase 1b clinical trial (Stage 1) investigating SGT-210 (topical erlotinib) in patients with Darier disease has been challenged by the limited number of eligible patients in Israel. As a result, only seven
                  subjects who completed the treatment were enrolled so far. Consequently, Sol-Gel has decided to conclude the current phase of the trial and to proceed with an open-label extension in which all enrolled patients will receive active
                  treatment with SGT-210. Sol-Gel will release the results of Stage 1 of the trial in December 2025.<br>
                </div>
              </td>
            </tr>

        </table>
        <br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z87a577ee5a2e42d3a3b45afadf7b30a6">

          <tr>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>On September 4, 2025, Sol-Gel announced Health Canada marketing approval of EPSOLAY for the treatment of inflammatory lesions of rosacea in adults.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zef9780c1143742f8ac5b275de18d8214">

        <tr>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>On August 19, 2025, Sol-Gel signed an additional license agreement for the commercialization of TWYNEO and EPSOLAY in Australia and New Zealand with Viatris Pty Ltd, a subsidiary of Viatris Inc. (NASDAQ: VTRS). This agreement is in
              addition to the seven agreements Sol-Gel signed during 2024 in various territories covering most European countries, South Africa and South Korea. These already signed agreements, together with agreements we anticipate signing in the future
              covering Latin American countries, Spain and Portugal, are expected to provide upfront and regulatory milestone payments of up to $3.7 million.</div>
            <div style="margin-left: 18pt; line-height: 1.25; font-weight: bold;"> <br>
            </div>
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"> <font style="font-weight: normal;">Based on the forecasts received from Sol-Gel&#8217;s current and potential partners, Sol-Gel now expects that TWYNEO
                and EPSOLAY will launch in the majority of these new territories in 2028 and 2027 respectively, and following launch, these transactions are anticipated to provide Sol-Gel with an annual royalty revenue stream with the potential to grow
                gradually to approximately $10 million for the year 2031 and further.</font></div>
            <div> </div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-weight: bold;"><br>
      Mr. Mori Arkin, Executive Chairman of Sol-Gel, stated:<font style="font-weight: normal;"> "Sol-Gel continued to make steady progress in the third quarter as we advance our late-stage pipeline in dermatologic rare diseases. Our pivotal Phase 3 trial
        of SGT-610 for Gorlin syndrome is ongoing, and we remain focused on executing this study to deliver top-line results in the fourth quarter of 2026. We are particularly excited about the opportunity of at least doubling the potential of this
        important drug by adding the unmet need of high-frequency BCC."</font></div>
    <div style="line-height: 1.25; font-weight: normal;">&#160;</div>
    <div style="line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal;"><font style="font-family: 'Times New Roman', Times, serif;">Mr. Arkin further commented "The recently announced Health Canada approval of
          EPSOLAY, alongside our existing ex-U.S. partnerships for TWYNEO and EPSOLAY, underscores our ability to unlock the value of our approved products through collaborations that provide non-dilutive revenue streams. We are delighted that additional
          companies with strong market presence in their territories have joined our growing partnership network. The number of territories and the identity of our partners make us confident about reaching our target of $10 million EBITDA from this
          business alone, by 2031. As we look ahead, we remain committed to advancing SGT-610 and SGT-210 to support our strategy of becoming a leader in rare dermatological diseases and to create long-term value for patients and shareholders."<br>
        </font></font>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Financial Results for the Third Quarter 2025</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">Total revenue for the third quarter was $0.4 million, which primarily consisted of license revenue from ex-US licensing agreements, compared to total revenue of $5.4 million for the same period in 2024, which primarily
      consisted of $0.4 million royalty revenue from Galderma, $0.6 royalty revenue from Searchlight, $3.8 million under the agreement with Padagis and $0.5 million under the ex-US licensing agreements.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">Research and development expenses were $5.7 million compared to $4.8 million for the same period in 2024. The increase of $0.9 million was primarily attributed to an increase of $0.8 million in manufacturing development
      expenses related to SGT-610 and an increase of $0.7 million in clinical trial expenses for SGT-610, offset by a decrease of $0.4 million in professional expenses related to ex-US activities in EPSOLAY and TWYNEO and a decrease of $0.3 million in
      professional expenses related to a generic product candidate.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">General and administrative expenses were $1 million compared to $1.4 million for the same period in 2024. The decrease is mainly attributed to a decrease in payroll and expenses due to the adoption of cost saving
      measures during 2024.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">Sol-Gel reported a net loss of $5.9 million for the third quarter of 2025 and loss of $2.13 per basic and diluted share, compared to a net loss of $0.4 million and loss of $0.13 per basic and diluted share for the same
      period in 2024.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">As of September 30, 2025, Sol-Gel had $6.8 million in cash, cash equivalents, and deposits and $14.1 million in marketable securities for a total balance of $20.9 million. The Company expects its cash resources to fund
      cash requirements into the first quarter of 2027.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; font-weight: bold;">About TWYNEO and EPSOLAY</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">TWYNEO is a topical cream containing a fixed-dose combination of tretinoin, 0.1%, and benzoyl peroxide, 3%, cream for the treatment of acne vulgaris in adults and pediatric patients 9 years of age
      and older. TWYNEO is the first acne treatment that contains a fixed-dose combination of benzoyl peroxide and tretinoin. Tretinoin and benzoyl peroxide are widely prescribed separately for acne vulgaris; however, benzoyl peroxide causes degradation of
      the tretinoin molecule, thereby potentially reducing its effectiveness if used at the same time or combined in the same formulation. TWYNEO uses silica (silicon dioxide) core shell structures to separately micro-encapsulate tretinoin crystals and
      benzoyl peroxide crystals enabling inclusion of the two active ingredients in the cream.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">EPSOLAY is a topical cream containing benzoyl peroxide (BPO), 5%, for the treatment of bumps and blemishes (inflammatory lesions) of rosacea in adults.&#160;EPSOLAY utilizes a proprietary, patented
      technology to encapsulate BPO within silica-based microcapsules to create a barrier between the medication and the skin. The silica-based shell is designed to slowly release BPO over time to provide tolerable and effective treatment.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">About Gorlin Syndrome and SGT-610</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">SGT-610, a hedgehog signaling pathway blocker, has the potential to be the first ever treatment for prevention of BCCs in Gorlin syndrome patients, if approved. Gorlin syndrome, an autosomal dominant
      genetic disorder affecting approximately 1 in 27,000-31,000 people in the&#160;U.S., is mostly caused by inheritance of one defective copy of the tumor suppressor patched homolog 1 (PTCH1) gene. Normally, the PTCH1 gene blocks the smoothened, frizzle
      class receptor (SMO) gene, turning off the hedgehog signaling pathway when it is not needed. Mutations in the PTCH1 gene may cause a loss of PTCH1 function, release of SMO, and may allow BCC tumor cells to divide uncontrollably. Patidegib, the active
      substance in SGT-610, is designed to block the SMO signal, thus, allowing cells to function normally and reducing the production of new tumors.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">3</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">About Sol-Gel Technologies</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Sol-Gel Technologies Ltd.&#160;is a dermatology company focused on identifying, developing and commercializing or partnering drug products to treat skin diseases.&#160;Sol-Gel&#160;developed TWYNEO which is
      approved by the FDA for the treatment of acne vulgaris in adults and pediatric patients nine years of age and older; and EPSOLAY, which is approved by the FDA for the treatment of inflammatory lesions of rosacea in adults.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Company&#8217;s pipeline also includes Phase 3 clinical trial of Orphan and breakthrough drug candidate SGT-610, which is a new topical hedgehog inhibitor being developed to prevent the new basal cell
      carcinoma lesions in patients with Gorlin syndrome that is expected to have an improved safety profile compared to oral hedgehog inhibitors as well as topical drug candidate SGT-210 under investigation for the treatment of&#160;rare hyper keratinization
      disorders.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">For additional information, please visit our new website: www.sol-gel.com</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Forward Looking Statements</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">This press release contains &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of
      historical fact should be considered forward-looking statements, including, but not limited to the amounts expected to be received under our current and future licensing agreements our expected cash runway, the size of the markets for SGT-610 and
      SGT-210, t the timeline for advancing SGT-610 and SGT-210, including the timing for top-line results and the timing for payments from Mayne Pharma. In some cases, you can identify forward-looking statements by terminology such as &#8220;believe,&#8221; &#8220;may,&#8221;
      &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;should,&#8221; &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; or the negative of these terms or other similar expressions. Forward-looking statements are based on information we have when those statements are
      made or our management&#8217;s current expectations and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors
      that could cause such differences include, but are not limited to, lower than anticipated annual revenue from our current and future licensing agreements or a delay in generating revenue, the risk that the market for SGT-610 and SGT-210 will not be
      as anticipated, including with respect to High-Frequency BCC for SGT-610, our ability to enter into further collaborations, a delay in the timing of our clinical trials, top-line results and regulatory filings, a delay in receipt of payments from
      Mayne Pharma and others, the success of our clinical trials, and an increase in our anticipated costs and expenses, as well as the following factors: (i) the adequacy of our financial and other resources, particularly in light of our history of
      recurring losses and the uncertainty regarding the adequacy of our liquidity to pursue our complete business objectives; (ii) our ability to complete the development of our product candidates; (iii) our ability to find suitable co-development
      partners; (iv) our ability to obtain and maintain regulatory approvals for our product candidates in our target markets, the potential delay in receiving such regulatory approvals and the possibility of adverse regulatory or legal actions relating to
      our product candidates even if regulatory approval is obtained; (v) our collaborators&#8217; ability to commercialize our pharmaceutical product candidates; (vi) our ability to obtain and maintain adequate protection of our intellectual property; (vii) our
      collaborators&#8217; ability to manufacture our product candidates in commercial quantities, at an adequate quality or at an acceptable cost; (viii) our collaborators&#8217; ability to establish adequate sales, marketing and distribution channels; (ix)
      acceptance of our product candidates by healthcare professionals and patients; (x) the possibility that we may face third-party claims of intellectual property infringement; (xi) the timing and results of clinical trials that we may conduct or that
      our competitors and others may conduct relating to our or their products; (xii) intense competition in our industry, with competitors having substantially greater financial, technological, research and development, regulatory and clinical,
      manufacturing, marketing and sales, distribution and personnel resources than we do; (xiii) potential product liability claims; (xiv) potential adverse federal, state and local government regulation in the United States, China, Europe or Israel; and
      (xv) loss or retirement of key executives and research scientists; (xvi) general market, political and economic conditions in the countries in which the Company operates; and, (xvii) the current war between Israel and Hamas and any deterioration of
      the war in Israel into a broader regional conflict involving Israel with other parties. These factors and other important factors discussed in the Company's Annual Report on Form 20-F filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on March
      13, 2024, and our other reports filed with the SEC, could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Except as required by law, we undertake no obligation to update any
      forward-looking statements in this press release.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">Sol-Gel Contact:</div>
    <div style="line-height: 1.25;">Eyal Ben-Or</div>
    <div style="line-height: 1.25;">Chief Financial Officer</div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><u>info@sol-gel.com</u></div>
    </div>
    <div style="line-height: 1.25;">+972-8-9313429</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><img height="40" width="198" src="image1.jpg"></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">Source: Sol-Gel Technologies Ltd.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">4</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">SOL-GEL TECHNOLOGIES LTD.</div>
    <div style="text-align: center; line-height: 1.25;">CONDENSED CONSOLIDATED BALANCE SHEETS</div>
    <div style="text-align: center; line-height: 1.25;">(U.S. dollars in thousands)</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">(Unaudited)</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="cfttable" id="zf505e05a0aeb4c678170559a1a0032ca" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

        <tr>
          <td valign="bottom" style="vertical-align: top;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">December 31,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">September 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2024</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">2025</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">A s s e t s</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">CURRENT ASSETS</font>:</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; text-indent: 14.2pt; line-height: 1.25;">Cash and cash equivalents</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">19,489</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">6,705</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: justify; text-indent: 14.2pt; line-height: 1.25;">Bank deposits</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">12</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">12</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; text-indent: 14.2pt; line-height: 1.25;">Marketable securities</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">4,425</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">14,126</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: justify; text-indent: 14.2pt; line-height: 1.25;">Accounts receivables</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">3,595</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">9,846</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; text-indent: 14.2pt; line-height: 1.25;">Prepaid expenses and other current assets</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">3,774</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">962</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">TOTAL CURRENT ASSETS</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">31,295</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">31,651</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">NON-CURRENT ASSETS:</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; text-indent: 14.2pt; line-height: 1.25;">Restricted long-term deposits and cash equivalents</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">1,291</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">1,312</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: justify; text-indent: 14.2pt; line-height: 1.25;">Long-term receivables</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">1,024</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; text-indent: 14.2pt; line-height: 1.25;">Property and equipment, net</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">202</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">145</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: justify; text-indent: 14.2pt; line-height: 1.25;">Operating lease right-of-use assets</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">1,426</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">1,132</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; text-indent: 14.2pt; line-height: 1.25;">Other long-term assets</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">13</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: justify; text-indent: 14.2pt; line-height: 1.25;">Funds in respect of employee rights upon retirement</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">595</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">352</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">TOTAL NON-CURRENT ASSETS</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">4,551</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">2,941</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">TOTAL ASSETS</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">$</div>
            </div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">35,846</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">$</div>
            </div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">34,592</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Liabilities and shareholders' equity</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">CURRENT LIABILITIES:</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; text-indent: 14.2pt; line-height: 1.25;">Accounts payable</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">1,265</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">828</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: justify; text-indent: 14.2pt; line-height: 1.25;">Other accounts payable</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">3,590</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">4,827</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; text-indent: 14.2pt; line-height: 1.25;">Current maturities of operating leases</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">430</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">491</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">TOTAL CURRENT LIABILITIES</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">5,285</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">6,146</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">LONG-TERM LIABILITIES</font>:</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; text-indent: 14.2pt; line-height: 1.25;">Operating leases liabilities</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">878</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">592</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: justify; text-indent: 14.2pt; line-height: 1.25;">Liability for employee rights upon retirement</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">833</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">424</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; text-indent: 14.2pt; line-height: 1.25;">Other long-term Liability</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">-</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">1,400</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">TOTAL LONG-TERM LIABILITIES</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">1,711</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">2,416</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">TOTAL LIABILITIES</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">6,996</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">8,562</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: justify; text-indent: -16.149pt; margin-left: 16.149pt; line-height: 1.25; font-weight: bold;">SHAREHOLDERS' EQUITY:</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -7.05pt; margin-left: 22.9pt; line-height: 1.25;">Ordinary Shares, NIS 1 par value &#8211; authorized: 5,000,000 as of December 31, 2024 and September 30, 2025; issued and outstanding: 2,785,787 as of December 31, 2024 and
              September 30, 2025 *.</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">774</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">774</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%;">
            <div style="text-align: justify; text-indent: 14.2pt; line-height: 1.25;">Additional paid-in capital</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">258,959</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">259,279</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; text-indent: 14.2pt; line-height: 1.25;">Accumulated deficit</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">(230,883</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">)</div>
            </div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">(234,023</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">)</div>
            </div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
            <div style="text-align: justify; text-indent: -20.35pt; margin-left: 20.35pt; line-height: 1.25; font-weight: bold;">TOTAL SHAREHOLDERS' EQUITY</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">28,850</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">26,030</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">$</div>
            </div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">35,846</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">$</div>
            </div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">34,592</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>

    </table>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">5</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">SOL-GEL TECHNOLOGIES LTD.</div>
    <div style="text-align: center; line-height: 1.25;">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</div>
    <div style="text-align: center; line-height: 1.25;">(U.S. dollars in thousands)</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">(Unaudited)</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="cfttable" id="z2e4d23c20e674baa8ae3265a80672b9a" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold; text-indent: 1pt;">Nine months ended</div>
              <div style="text-align: center; line-height: 1.25; font-weight: bold; text-indent: 1pt;">September 30</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold; text-indent: 1pt;">Three months ended</div>
              <div style="text-align: center; line-height: 1.25; font-weight: bold; text-indent: 1pt;">September 30</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold; text-indent: 1pt;"> 2024</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold; text-indent: 1pt;">2025</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold; text-indent: 1pt;">2024</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold; text-indent: 1pt;">2025</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -14.2pt; margin-left: 15.9pt; line-height: 1.25; font-weight: bold;">REVENUE</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">11,260</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">18,692</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">5,361</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">400</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="text-indent: -14.2pt; margin-left: 15.9pt; line-height: 1.25; font-weight: bold;">RESEARCH AND DEVELOPMENT EXPENSES</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">12,606</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">19,220</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">4,823</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">5,731</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -14.2pt; margin-left: 15.9pt; line-height: 1.25; font-weight: bold;">GENERAL AND ADMINISTRATIVE EXPENSES</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">4,569</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">3,599</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">1,366</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">957</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;">
            <div style="text-indent: -14.2pt; margin-left: 15.9pt; line-height: 1.25; font-weight: bold;">OPERATING LOSS</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(5,915</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(4,127</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(828</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(6,288</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -14.2pt; margin-left: 15.9pt; line-height: 1.25;"><font style="font-weight: bold;">FINANCIAL INCOME, </font>net</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">1,181</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">987</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">462</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">346</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;">
            <div style="text-indent: -14.2pt; margin-left: 15.9pt; line-height: 1.25; font-weight: bold;">NET LOSS FOR THE PERIOD</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">$</div>
            </div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">(4,734</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">)</div>
            </div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">$</div>
            </div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">(3,140</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">)</div>
            </div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">$</div>
            </div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">(366</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">)</div>
            </div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">$</div>
            </div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">(5,942</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">)</div>
            </div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-indent: -14.2pt; margin-left: 15.9pt; line-height: 1.25; font-weight: bold;">BASIC AND DILUTED LOSS PER ORDINARY SHARE</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">(1.7</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">)</div>
            </div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">(1.13</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">)</div>
            </div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">(0.13</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">)</div>
            </div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">(2.13</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">)</div>
            </div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;">
            <div style="text-indent: -14.2pt; margin-left: 15.9pt; line-height: 1.25; font-weight: bold;">WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF BASIC AND DILUTED LOSS PER SHARE *</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">2,785,787</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">2,785,787</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">2,785,787</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">2,785,787</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">*All share amounts have been retroactively adjusted to reflect a 1-for-10 reverse share split.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; text-align: center;"> <font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">6</font>
      <hr style="border-width: 1px medium 4px; border-style: solid none; border-color: black -moz-use-text-color; -moz-border-top-colors: none; -moz-border-right-colors: none; -moz-border-bottom-colors: none; -moz-border-left-colors: none; border-image: none; height: 10px; color: rgb(255, 255, 255); background-color: rgb(255, 255, 255); margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "> P,# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCXE_'+XCVXNKKQ9\3_BE\1O$-AIT$M]=ZAXE\6^+?$FL7$&G:=:?:+N6YO\
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M(G5XGA\%BZB9O#OAC8%O8%36M?-Q=7%EIFA_IU_P<%?MK:I\// OAC]C_P
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M33X=)\,>!/"N@>$/#^F6ZA8;'1O#FE6NDZ=:QX R(;2TB0N1ND8%W)9B3U]
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M>YE::ZGL]-:YMKWP[?S3.]P]_P"&M0TF:XN6,FH"^C:6"0 _T8J*_FV^"/\
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M?UU_81_X(0?&CXSW^C?$#]JJ+5/@C\*H[F.Z/@:1$A^+/C.T2,2+ ;*02P^
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M]VX?_A&OVC?A%JY!_=C7/#OC+P[N7>@RYL8/$VP^67;:HD&]53=AS(G]@]%
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M1_Q#>_LF?]%M_:)_\&'PU_\ G=U_0_10!_/!_P 0WO[)G_1;?VB?_!A\-?\
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M<Q^&_A7K/B)P-P\U()=3\9^%U)V9"2O" &P6A(&#][?##_@WI_8C\'PV\GQ
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M:B^D:I]B\!VEY_9VI+;&ROOLEU;77V::7[/<0R[)%_?VB@!  H"J     !@
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M.;;E.3<I2;W;;NVPHHHKT"0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
3 "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image1.jpg
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !@ =8# 2(  A$! Q$!_\0
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MJ&H:9I?B31/",-[=.#-/_9'AG2[19&(M;2VA"1( 26W_  6V_P""9=S,D/\
MPT?+;F1T17N?@_\ '2*'<YVC?*/AHZ1(#C?)*4C0'<[J@9E^JOA9^W7^QO\
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MJ%GK6A:[I,MW;7EK%J_A_7M-TW6M+DN;2ZMEOK"#[1;7$'F0O_&#\/O^"_\
M_P %!O!D<B>)-5^$/Q:+QK&LWC_X:0Z9+"RMEIXO^%6:Q\-8?.<?*1-#-
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MYGV;R)?(V?:)MW[R?\.(_P#@G!_T2WQG_P"'8^('_P NZ_-[_@V7_P";V/\
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MM?AOXSTR75/"_A_[5--+=W']@:WI'C&UL%FV6^F^'9- T/3DCLM*BAB^5_\
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MBBBO7)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
5BB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
